
Twist Bioscience (TWST) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Twist Bioscience (TWST) publicó su última previsión de agosto 3, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $456M - $457M para el período.
En comparación con la previsión anterior, Twist Bioscience elevado redujo su previsión de ingresos desde un rango anterior de $442M - $447M.
Twist Bioscience ha emitido 38 actualizaciones de orientación entre el noviembre 18, 2022 y el agosto 3, 2026. During this period, the company raised its outlook 16 times and lowered it 14 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.24 | $-0.53 | $-0.50 | $-0.46 |
| Actual | $-0.56 | $-0.59 | $-0.50 | $-0.45 |
| Surprise | -133.3% | -11.3% | 0.00% | +2.17% |
| Revenue | ||||
| Estimate | $114.5M | $107.7M | $102.7M | $97.4M |
| Actual | $118.4M | $110.7M | $103.7M | $99.0M |
| Surprise | +3.36% | +2.80% | +0.95% | +1.69% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.11 | $-0.12 | $-0.47 | $-0.41 |
| Revenue | ||||
| Consensus | $123.5M | $125.8M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Aug 3, 2026 | $-0.56 | $-0.24 | -133.3 % |
| Q2 | May 4, 2026 | $-0.59 | $-0.53 | -11.3 % |
| Q1 | Feb 2, 2026 | $-0.50 | $-0.50 | 0.00 % |
| Q4 | Nov 14, 2025 | $-0.45 | $-0.46 | 2.17 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Aug 3, 2026 | $118.38M | $114.53M | 3.36 % |
| Q2 | May 4, 2026 | $110.72M | $107.70M | 2.80 % |
| Q1 | Feb 2, 2026 | $103.70M | $102.72M | 0.95 % |
| Q4 | Nov 14, 2025 | $99.01M | $97.37M | 1.69 % |